Literature DB >> 289343

Osteosarcoma: histological evaluation and grading.

P Meister, E Konrad, G Lob, G Janka, W Keyl, H Stürz.   

Abstract

With 60 cases of osteosarcomas a histological evaluation from + to +++ carried out for mitoses, osteoid formation, presence of multinucleated giant cells, and tumor necrosis. A subclassification in osteoblastic, chondroblastic, and fibroblastic type of osteosarcoma (according to Dahlin) and a histological grading from + to +++ based on degree of cellular atypism was also done. In our material no relations between these three types of osteosarcoma and chance for survival became evident. There was, however, a significant correlation between grade of atypism and rate of mitoses. Grading of oestosarcomas from + to +++ showed that cases with grade III osteosarcoma remained only seldomly without metastases during the course of the disease. Grade I osteosarcomas and also grade II tumors showed a higher number of patients with 2-year survival. However, neither correlation between tumor grade and incidence of metastases, nor with chances for survival were statistically significant. Nevertheless, characterization of osteosarcomas, by a histological grading from + to +++ based on cellular atypism and mitotic count is advisable, in addition to the TNM stages. This histological grading appeared to be more practicable than subclassifications of osteosarcoma by type which had been tested by us in a previous study (Konrad et al., in press).

Entities:  

Mesh:

Year:  1979        PMID: 289343     DOI: 10.1007/bf00433573

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  19 in total

1.  Osteosarcoma. A review of 96 cases.

Authors:  A LINDBOM; G SODERBERG; H J SPJUT
Journal:  Acta radiol       Date:  1961-07       Impact factor: 1.990

2.  Osteogenic sarcoma; a critical analysis of 430 cases.

Authors:  M B COVENTRY; D C DAHLIN
Journal:  J Bone Joint Surg Am       Date:  1957-07       Impact factor: 5.284

3.  FACTORS INFLUENCING THE PROGNOSIS IN OSTEOGENIC SARCOMA.

Authors:  B L Coley; J L Pool
Journal:  Ann Surg       Date:  1940-12       Impact factor: 12.969

4.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

5.  Osteogenic sarcoma. A study of six hundred cases.

Authors:  D C Dahlin; M B Coventry
Journal:  J Bone Joint Surg Am       Date:  1967-01       Impact factor: 5.284

6.  Osteogenic sarcoma. Analysis of factors influencing prognosis in 100 cases.

Authors:  I F Goidanich; L Battaglia; L Lenzi; E Silva
Journal:  Clin Orthop Relat Res       Date:  1966 Sep-Oct       Impact factor: 4.176

7.  Osteosarcoma. A multifactorial clinical and histopathological study with special regard to therapy and survival.

Authors:  S E Larsson; R Lorentzon; H Wedrén; L Boquist
Journal:  Acta Orthop Scand       Date:  1978-12

8.  Malignant (fibrous) histiocytoma of bone--fact or fancy?.

Authors:  D C Dahlin; K K Unni; T Matsuno
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

9.  Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54.

Authors:  G Uribe-Botero; W O Russell; W W Sutow; R G Martin
Journal:  Am J Clin Pathol       Date:  1977-05       Impact factor: 2.493

10.  Juxtacortical (parosteal) osteogenic sarcoma: histological grading and prognosis.

Authors:  S C Ahuja; A B Villacin; J Smith; P G Bullough; A G Huvos; R C Marcove
Journal:  J Bone Joint Surg Am       Date:  1977-07       Impact factor: 5.284

View more
  8 in total

1.  Intentional marginal resection of periosteal osteosarcoma in combination with neoadjuvant chemotherapy: A report of two cases and a review of the literature.

Authors:  Yu Chen; Song-Feng Xu; Ming Xu; Xiu-Chun Yu
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

2.  Fusion between cancer cells and myofibroblasts is involved in osteosarcoma.

Authors:  Ling Yu; Weichun Guo; Shenghao Zhao; Fuan Wang; Yong Xu
Journal:  Oncol Lett       Date:  2011-07-14       Impact factor: 2.967

3.  Cytologic anaplasia is a prognostic factor in osteosarcoma biopsies, but mitotic rate or extent of spontaneous tumor necrosis are not: a critique of the College of American Pathologists Bone Biopsy template.

Authors:  Justin Mm Cates; William D Dupont
Journal:  Mod Pathol       Date:  2016-09-23       Impact factor: 7.842

Review 4.  Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.

Authors:  Xing Dai; Wei Ma; Xijing He; Rajiv Kumar Jha
Journal:  Med Sci Monit       Date:  2011-08

5.  MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the SOCS1/NF-κB signalling pathway through negatively targeting DNMT3B.

Authors:  Hao-Li Gong; Ye Tao; Xin-Zhan Mao; De-Ye Song; Di You; Jiang-Dong Ni
Journal:  Int J Mol Med       Date:  2019-07-24       Impact factor: 4.101

6.  Periosteal Osteosarcoma: A Review of 17 Cases with Mean Follow-up of 52 Months.

Authors:  Matthew P Revell; Neeta Deshmukh; Robert J Grimer; Simon R Carter; Roger M Tillman
Journal:  Sarcoma       Date:  2002

7.  Predictive model for the 5-year survival status of osteosarcoma patients based on the SEER database and XGBoost algorithm.

Authors:  Jiuzhou Jiang; Hao Pan; Mobai Li; Bao Qian; Xianfeng Lin; Shunwu Fan
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

8.  Long non‑coding RNA H19 regulates LASP1 expression in osteosarcoma by competitively binding to miR‑29a‑3p.

Authors:  Hao Jin; Huan Wang; Xin Jin; Wenbo Wang
Journal:  Oncol Rep       Date:  2021-07-30       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.